120 related articles for article (PubMed ID: 8930673)
1. A novel mechanism for virus-induced autoimmunity in humans.
Nauclér CS; Larsson S; Möller E
Immunol Rev; 1996 Aug; 152():175-92. PubMed ID: 8930673
[TBL] [Abstract][Full Text] [Related]
2. Cytomegalovirus-induced CD13-specific autoimmunity--a possible cause of chronic graft-vs-host disease.
Soderberg C; Larsson S; Rozell BL; Sumitran-Karuppan S; Ljungman P; Moller E
Transplantation; 1996 Feb; 61(4):600-9. PubMed ID: 8610388
[TBL] [Abstract][Full Text] [Related]
3. CD13-specific autoimmunity in cytomegalovirus-infected immunocompromised patients.
Soderberg C; Sumitran-Karuppan S; Ljungman P; Moller E
Transplantation; 1996 Feb; 61(4):594-600. PubMed ID: 8610387
[TBL] [Abstract][Full Text] [Related]
4. Productive cytomegalovirus (CMV) infection exclusively in CD13-positive peripheral blood mononuclear cells from CMV-infected individuals: implications for prevention of CMV transmission.
Larsson S; Söderberg-Nauclér C; Möller E
Transplantation; 1998 Feb; 65(3):411-5. PubMed ID: 9484762
[TBL] [Abstract][Full Text] [Related]
5. Correlation between donor cytomegalovirus immunity and chronic graft-versus-host disease after allogeneic bone marrow transplantation.
Jacobsen N; Andersen HK; Skinhøj P; Ryder LP; Platz P; Jerne D; Faber V
Scand J Haematol; 1986 May; 36(5):499-506. PubMed ID: 3016881
[TBL] [Abstract][Full Text] [Related]
6. Autoimmune diseases and autoimmunity post-bone marrow transplantation.
Sherer Y; Shoenfeld Y
Bone Marrow Transplant; 1998 Nov; 22(9):873-81. PubMed ID: 9827815
[TBL] [Abstract][Full Text] [Related]
7. Neutralization of human cytomegalovirus by human CD13-specific antibodies.
Giugni TD; Söderberg C; Ham DJ; Bautista RM; Hedlund KO; Möller E; Zaia JA
J Infect Dis; 1996 May; 173(5):1062-71. PubMed ID: 8627055
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for cytomegalovirus reactivation after CD6+ T-cell-depleted allogeneic bone marrow transplantation.
Lin TS; Zahrieh D; Weller E; Alyea EP; Antin JH; Soiffer RJ
Transplantation; 2002 Jul; 74(1):49-54. PubMed ID: 12134098
[TBL] [Abstract][Full Text] [Related]
9. Anti-CD13 Abs in children with extensive chronic GVHD and their relation to soluble CD13 after allogeneic blood and marrow transplantation from a Children's Oncology Groups Study, ASCT0031.
Cuvelier GD; Kariminia A; Fujii H; Aslanian S; Wall D; Goldman F; Grupp SA; Dunn SE; Krailo M; Shapiro LH; Gilman A; Schultz KR
Bone Marrow Transplant; 2010 Nov; 45(11):1653-7. PubMed ID: 20190833
[TBL] [Abstract][Full Text] [Related]
10. A pilot study on the role of cytomegalovirus & human herpesvirus-6 infections in Indian bone marrow transplant recipients.
Finny GJ; Mathews V; Abraham P; Abraham M; Chandy M; Srivastava A; Nitsche A; Siegert W; Sridharan G
Indian J Med Res; 2001 Aug; 114():39-46. PubMed ID: 11785448
[TBL] [Abstract][Full Text] [Related]
11. Prevention of graft-versus-host disease by selective depletion of CD6-positive T lymphocytes from donor bone marrow.
Soiffer RJ; Murray C; Mauch P; Anderson KC; Freedman AS; Rabinowe SN; Takvorian T; Robertson MJ; Spector N; Gonin R
J Clin Oncol; 1992 Jul; 10(7):1191-200. PubMed ID: 1607923
[TBL] [Abstract][Full Text] [Related]
12. Incidence, risk factors, and outcome of cytomegalovirus viremia and gastroenteritis in patients with gastrointestinal graft-versus-host disease.
Bhutani D; Dyson G; Manasa R; Deol A; Ratanatharathorn V; Ayash L; Abidi M; Lum LG; Al-Kadhimi Z; Uberti JP
Biol Blood Marrow Transplant; 2015 Jan; 21(1):159-64. PubMed ID: 25445637
[TBL] [Abstract][Full Text] [Related]
13. Cytomegalovirus infection in leucocytes after bone marrow transplantation demonstrated by mRNA in situ hybridization.
Link H; Battmer K; Stumme C
Br J Haematol; 1993 Nov; 85(3):573-7. PubMed ID: 8136281
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for cytomegalovirus, hepatitis B and C virus reactivation after bone marrow transplantation.
Zekri AR; Mohamed WS; Samra MA; Sherif GM; El-Shehaby AM; El-Sayed MH
Transpl Immunol; 2004 Dec; 13(4):305-11. PubMed ID: 15589744
[TBL] [Abstract][Full Text] [Related]
15. Graft-versus-leukaemia activity associated with CMV-seropositive donor, post-transplant CMV infection, young donor age and chronic graft-versus-host disease in bone marrow allograft recipients. The Nordic Bone Marrow Transplantation Group.
Jacobsen N; Badsberg JH; Lönnqvist B; Ringdén O; Volin L; Rajantie J; Nikoskelainen J; Keiding N
Bone Marrow Transplant; 1990 Jun; 5(6):413-8. PubMed ID: 2164434
[TBL] [Abstract][Full Text] [Related]
16. Role of target organ infection with cytomegalovirus in the pathogenesis of graft-versus-host disease.
Appleton AL; Sviland L; Peiris JS; Taylor CE; Wilkes J; Green MA; Pearson AD; Proctor SJ; Hamilton PJ; Cant AJ
Bone Marrow Transplant; 1995 Apr; 15(4):557-61. PubMed ID: 7655381
[TBL] [Abstract][Full Text] [Related]
17. Pretransplant herpes virus serology and chronic graft-versus-host disease.
Boström L; Ringdén O; Sundberg B; Ljungman P; Linde A; Nilsson B
Bone Marrow Transplant; 1989 Sep; 4(5):547-52. PubMed ID: 2551436
[TBL] [Abstract][Full Text] [Related]
18. Cytomegalovirus immunity in allogeneic marrow grafting.
Gratama JW; Middeldorp JM; Sinnige LG; van der Meer JW; D'Amaro J; Jansen J; Zwaan FE; Brand A; de Gast GC; The TH
Transplantation; 1985 Nov; 40(5):510-4. PubMed ID: 2997951
[TBL] [Abstract][Full Text] [Related]
19. Natural cytotoxic activity against cytomegalovirus-infected target cells following marrow transplantation.
Bowden RA; Day LM; Amos DE; Meyers JD
Transplantation; 1987 Oct; 44(4):504-8. PubMed ID: 2823422
[TBL] [Abstract][Full Text] [Related]
20. Cellular immunity to vaccinations and herpesvirus infections after bone marrow transplantation.
Gratama JW; Verdonck LF; van der Linden JA; van Heugten JG; Kreeft HA; D'Amaro J; Zwaan FE; de Gast GC
Transplantation; 1986 Jun; 41(6):719-24. PubMed ID: 3012833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
